1. Home
  2. GLMD vs CMCT Comparison

GLMD vs CMCT Comparison

Compare GLMD & CMCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • CMCT
  • Stock Information
  • Founded
  • GLMD 2000
  • CMCT 1993
  • Country
  • GLMD Israel
  • CMCT United States
  • Employees
  • GLMD N/A
  • CMCT N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • CMCT Real Estate Investment Trusts
  • Sector
  • GLMD Health Care
  • CMCT Real Estate
  • Exchange
  • GLMD Nasdaq
  • CMCT Nasdaq
  • Market Cap
  • GLMD 6.6M
  • CMCT 5.5M
  • IPO Year
  • GLMD 2014
  • CMCT N/A
  • Fundamental
  • Price
  • GLMD $1.18
  • CMCT $9.14
  • Analyst Decision
  • GLMD Hold
  • CMCT
  • Analyst Count
  • GLMD 1
  • CMCT 0
  • Target Price
  • GLMD N/A
  • CMCT N/A
  • AVG Volume (30 Days)
  • GLMD 65.7K
  • CMCT 2.8M
  • Earning Date
  • GLMD 11-14-2025
  • CMCT 11-14-2025
  • Dividend Yield
  • GLMD N/A
  • CMCT N/A
  • EPS Growth
  • GLMD N/A
  • CMCT N/A
  • EPS
  • GLMD N/A
  • CMCT N/A
  • Revenue
  • GLMD N/A
  • CMCT $114,868,000.00
  • Revenue This Year
  • GLMD N/A
  • CMCT N/A
  • Revenue Next Year
  • GLMD N/A
  • CMCT N/A
  • P/E Ratio
  • GLMD N/A
  • CMCT N/A
  • Revenue Growth
  • GLMD N/A
  • CMCT N/A
  • 52 Week Low
  • GLMD $1.15
  • CMCT $4.03
  • 52 Week High
  • GLMD $3.61
  • CMCT $92.50
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 32.65
  • CMCT 67.21
  • Support Level
  • GLMD $1.16
  • CMCT $4.75
  • Resistance Level
  • GLMD $1.27
  • CMCT $6.36
  • Average True Range (ATR)
  • GLMD 0.08
  • CMCT 1.01
  • MACD
  • GLMD -0.02
  • CMCT 0.17
  • Stochastic Oscillator
  • GLMD 0.00
  • CMCT 62.66

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About CMCT Creative Media & Community Trust Corporation

Creative Media & Community Trust Corp is formed to invest in, own, and operate Class A and creative office investments in improving urban communities throughout the United States. It operates through segments such as office, hotel and multifamily properties and lending. The Office segment includes rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment relates to operations of hotel properties whereas, the lending segment refers to income from the yield and other related fee income earned on its loans receivable. The lending segment includes income recognized from the sale of government guaranteed portion of loans receivable, income from the yield on its loans receivable and other related fee income earned.

Share on Social Networks: